In less than a week’s time, families around the country will be sitting down to tuck into their traditional Christmas dinner.
Revance to be acquired for $900M+ as Botox trade secrets lawsuit continues
Revance Therapeutics, the maker of Botox competitor Daxxify, will be acquired for more than $900 million. Crown Laboratories will buy out … Sign up to